Pathos

About:

Pathos develops an AI-enabled drug discovery platform to reduce the medication development process.

Website: https://pathos.com

Top Investors: New Enterprise Associates, Lightbank, Builders VC, Revolution Growth

Description:

Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthrough therapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.